Cyramza Injection (Ramucirumab 500mg Infusion)

500mg Injection, Box

4.5 (154)

₹50,000

Cyramza 500mg Injection contains ramucirumab (Cyramza is actually its known brand name), an anticancer medication used in the treatment of non-small cell lung cancer, stomach (gastric) cancer, and colorectal cancer. It works by blocking VEGF receptor 2, cutting off the blood supply that tumors need to grow, which slows cancer cell growth and eventually leads to cell death. It is administered as an intravenous infusion by a healthcare professional, with dosage and frequency determined based on the patient’s condition.

Description

Introduction of Ramucirumab 500mg Infusion: 

Cyramza 500mg Injection contains Ramucirumab, a monoclonal antibody (VEGFR2 antagonist) used in the treatment of advanced gastric or gastro-oesophageal junction cancer, metastatic colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma.

Cyramza 500mg Injection is administered only by a trained healthcare professional as an intravenous infusion after dilution, usually once every 2 or 3 weeks. Your doctor will decide the dose and schedule based on your body weight, your condition, and whether it is combined with other cancer medicines such as paclitaxel. Store the vial in a refrigerator. It should never be self-administered.

High blood pressure, swelling of the ankles and feet, diarrhea, and headache are among the most common effects of this medicine. Your doctor will monitor your blood pressure and urine protein levels regularly during treatment. Inform your doctor immediately if you notice severe stomach pain, black or bloody stools, chest pain, sudden weakness or numbness, or unusual bleeding.

Uses Of Ramucirumab 500mg Infusion:

  • Advanced Gastric or Gastro-oesophageal Junction Cancer
  • Metastatic Colorectal Cancer
  • Non-Small Cell Lung Cancer (NSCLC)
  • Hepatocellular Carcinoma

Benefits Of Ramucirumab 500mg Infusion:

1. Gastric and Gastro-oesophageal Junction Cancer

Advanced stomach cancer depends on new blood vessels to keep growing. Cyramza 500mg Injection, used alone or with paclitaxel, blocks the signals that create these blood vessels, reducing the blood supply to the tumor and helping slow its growth.

2. Colorectal Cancer, Lung Cancer, and Liver Cancer

In metastatic colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma, Cyramza 500mg Injection, used together with other cancer treatments, helps limit tumor blood supply and supports control of disease progression.

3. In Cancer of colon and rectum

Cancer of the colon and rectum, otherwise called colorectal cancer (CRC) or inside cancer, is the advancement of cancer from two pieces of the digestive organ, to be specific, the colon or rectum. In this kind of cancer, the individual might see side effects like blood in the stool, an adjustment of defecations, weight reduction, and weariness. Cyramza 500mg Injection treats and furthermore brings down the gamble of growing further cancerous developments (polyps) and inside cancer.

It kills or stops the development of cancer cells and furthermore forestalls the augmentation of cancer cells. It is a successful, yet exceptionally harmful medication and you ought to talk about the dangers and benefits with your doctor. Abstain from drinking liquor or smoking while at the same time having this treatment and drink a lot of water to remain hydrated.

Mechanism Of Action Of Ramucirumab 500mg Infusion:

Ramucirumab 500mg Infusion is an anticancer drug. It works by hindering the ‘VEGF receptor 2’ subsequently removing the blood supply to the cancer cells. This eases back the development of cancer cells and in the end kills them.

Contact Us

Info Table
Packaging Size 50ml Vial
Composition RAMUCIRUMAB-500MG/50ML
Manufacturer/Marketer ELI LILLY
Consume Type Parenteral
Treatment Gastric Cancer | Colorectal Cancer | Lung Cancer | Liver Cancer
Prescription/Non prescription Prescription
Form Injection (Single Dose Vial)
Country of Origin Imported
Vendor Info
Benefits
Reviews

Description

Introduction of Ramucirumab 500mg Infusion: 

Cyramza 500mg Injection contains Ramucirumab, a monoclonal antibody (VEGFR2 antagonist) used in the treatment of advanced gastric or gastro-oesophageal junction cancer, metastatic colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma.

Cyramza 500mg Injection is administered only by a trained healthcare professional as an intravenous infusion after dilution, usually once every 2 or 3 weeks. Your doctor will decide the dose and schedule based on your body weight, your condition, and whether it is combined with other cancer medicines such as paclitaxel. Store the vial in a refrigerator. It should never be self-administered.

High blood pressure, swelling of the ankles and feet, diarrhea, and headache are among the most common effects of this medicine. Your doctor will monitor your blood pressure and urine protein levels regularly during treatment. Inform your doctor immediately if you notice severe stomach pain, black or bloody stools, chest pain, sudden weakness or numbness, or unusual bleeding.

Uses Of Ramucirumab 500mg Infusion:

  • Advanced Gastric or Gastro-oesophageal Junction Cancer
  • Metastatic Colorectal Cancer
  • Non-Small Cell Lung Cancer (NSCLC)
  • Hepatocellular Carcinoma

Benefits Of Ramucirumab 500mg Infusion:

1. Gastric and Gastro-oesophageal Junction Cancer

Advanced stomach cancer depends on new blood vessels to keep growing. Cyramza 500mg Injection, used alone or with paclitaxel, blocks the signals that create these blood vessels, reducing the blood supply to the tumor and helping slow its growth.

2. Colorectal Cancer, Lung Cancer, and Liver Cancer

In metastatic colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma, Cyramza 500mg Injection, used together with other cancer treatments, helps limit tumor blood supply and supports control of disease progression.

3. In Cancer of colon and rectum

Cancer of the colon and rectum, otherwise called colorectal cancer (CRC) or inside cancer, is the advancement of cancer from two pieces of the digestive organ, to be specific, the colon or rectum. In this kind of cancer, the individual might see side effects like blood in the stool, an adjustment of defecations, weight reduction, and weariness. Cyramza 500mg Injection treats and furthermore brings down the gamble of growing further cancerous developments (polyps) and inside cancer.

It kills or stops the development of cancer cells and furthermore forestalls the augmentation of cancer cells. It is a successful, yet exceptionally harmful medication and you ought to talk about the dangers and benefits with your doctor. Abstain from drinking liquor or smoking while at the same time having this treatment and drink a lot of water to remain hydrated.

Mechanism Of Action Of Ramucirumab 500mg Infusion:

Ramucirumab 500mg Infusion is an anticancer drug. It works by hindering the ‘VEGF receptor 2’ subsequently removing the blood supply to the cancer cells. This eases back the development of cancer cells and in the end kills them.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Cyramza Injection (Ramucirumab 500mg Infusion)”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Ramucirumab 500mg Infusion?
Ramucirumab 500mg Infusion contains ramucirumab, a monoclonal antibody that targets vascular endothelial growth factor receptor 2 (VEGFR-2). It is an anticancer medicine administered under the supervision of a qualified healthcare professional.
Ramucirumab may be used alone or in combination with other anticancer medicines for certain advanced cancers, including stomach or gastroesophageal junction cancer, non-small-cell lung cancer, colorectal cancer, and hepatocellular carcinoma. The specific indication depends on the patient’s condition and prescribed treatment protocol.
Ramucirumab 500mg Infusion is administered intravenously by a doctor or nurse in a hospital or medical facility. The infusion is generally given over approximately 30 to 60 minutes, with the dosage and treatment frequency determined by the treating oncologist.
Patients should inform their healthcare provider about high blood pressure, liver or thyroid problems, healing wounds, previous surgery, bleeding problems, pregnancy or breastfeeding, and all medicines or supplements they are taking. Blood pressure and urine may be monitored during treatment, and treatment may need to be adjusted around surgery.
Possible side effects may include diarrhea, mouth or throat sores, tiredness, high blood pressure, and infusion-related reactions. Serious reactions may include bleeding, blood clots, gastrointestinal perforation, wound-healing problems, and severe infusion reactions. Any severe or unusual symptoms should be reported promptly to a healthcare professional.
It works as a monoclonal antibody, blocking a protein that helps tumors grow new blood vessels, helping slow or stop the growth of stomach, lung, colorectal, and liver cancers. See MedlinePlus Drug Information for more.

Related products